photocoagulation is a surgical procedure in which an intense, focused beam of light — most commonly a laser — is directed at tissue to generate localized thermal energy that coagulates (clots and destroys) targeted structures. Unlike cryotherapy, which destroys tissue via freezing, photocoagulation destroys tissue via heat absorption, making it highly precise and well-suited for delicate anatomic targets like the retina. The underlying mechanism involves selective absorption of light energy (particularly in the visible green wavelength) by hemoglobin in red blood cells and melanin in retinal pigment epithelium, converting radiant energy into heat that denatures protein and seals vascular channels. It may be physiological in intent — such as prophylactic barrier laser around a retinal tear to prevent retinal detachment (H33.30–H33.32x) — or destructive in intent, as in panretinal photocoagulation (PRP) used to ablate ischemic peripheral retina in proliferative diabetic retinopathy (E11.359). Clinically relevant subtypes include focal/grid laser for diabetic macular edema (E11.311), PRP for proliferative retinopathy (E11.359), and choroidal photocoagulation for choroidal neovascularization (H35.32). It is commonly confused with photodynamic therapy (PDT), which uses a photosensitizing drug activated by light rather than direct thermal energy — an important coding and clinical distinction.
Noun-forming suffix — “process of,” “state resulting from” — converts the verb into an action noun
The word entered English in the 1950s–1960s as photocoagulation (noun), formed as a compound of the Greek combining form photo- (“light”) and the Latin coagulatio (“a curdling, clotting”), from coagulare — literally “the process of clotting by means of light.” The ruby laser was first applied to photocoagulation in the 1960s, with argon-ion lasers (green wavelength) emerging in 1969 and eventually being replaced by diode-pumped solid-state green lasers. The root coagul- (“to clot, to drive together”) connects photocoagulation to the broader coagul- root family: coagulation (the physiological process of blood clotting), anticoagulant (a drug preventing clot formation), and coagulopathy (a disorder of normal clotting). The combining form photo- is highly productive in medical terminology: photophobia, phototherapy, photodynamic therapy, photokeratitis, photoreceptor.
🔀 ALIASES / ALTERNATE TERMS
Photocoagulative(adjective form — appears in clinical collocations such as “photocoagulative treatment,” “photocoagulative burns,” “photocoagulative scar formation”)
Laser Photocoagulation(the most common clinical synonym; used interchangeably in ophthalmology; implies laser as the light source rather than xenon-arc)
Laser Coagulation(abbreviated synonym; used in surgical and retinal specialty literature; coded the same as photocoagulation)
Retinal Laser Surgery(lay and general clinical synonym; used in patient-facing documentation and Yale Medicine; encompasses all photocoagulative retinal procedures)
Panretinal Photocoagulation|PRP(the extensive scatter laser form targeting ischemic peripheral retina; used for proliferative diabetic retinopathy and proliferative retinopathies — CPT 67228)
Scatter Laser(informal clinical synonym for PRP/panretinal photocoagulation; seen in retinal specialist notes)
Focal/Grid Laser(targeted subtype used for diabetic macular edema — applies burns in a focal or grid pattern to leaking microaneurysms; ICD-10-CM E11.311, E10.311)
Prophylactic Laser(preventive subtype applied around retinal tears or lattice degeneration to prevent detachment; CPT 67145)
Barrage Laser(clinical synonym for prophylactic photocoagulation placed around a tear or hole as a barrier; commonly used in retina specialist documentation)
🔗 RELATED TERMS
cryotherapy / Cryopexy — the thermal-destruction alternative to photocoagulation using extreme cold rather than light-generated heat; used for retinal tears, ROP, and tumors; compare CPT 67141 (cryotherapy prophylaxis) vs. CPT 67145 (photocoagulation prophylaxis)
Coagulation — the underlying physiological process of blood clotting or tissue protein denaturation that photocoagulation intentionally induces at the target site
Photodynamic Therapy (PDT) — a related but mechanistically distinct procedure using a photosensitizing drug (verteporfin) activated by laser light; causes chemical rather than thermal destruction; CPT 67221; ICD-10-CM H35.32
Diabetic Retinopathy — the most common indication for photocoagulation; proliferative form (E11.359) requires PRP; nonproliferative form with macular edema (E11.311) requires focal/grid laser
Retinal Detachment — a key indication for photocoagulation; laser used prophylactically to seal tears/breaks before full detachment occurs (H33.30–H33.32x); CPT 67105 for detachment repair by photocoagulation
Choroidal Neovascularization (CNV) — abnormal new blood vessel growth beneath the retina; targeted by choroidal photocoagulation; ICD-10-CM H35.32; now often managed with anti-VEGF but photocoagulation remains a treatment option
Retinopathy of Prematurity (ROP) — a proliferative retinopathy in preterm infants treated with photocoagulation or cryotherapy; CPT 67229; ICD-10-CM H35.10–H35.17x
Age-Related Macular Degeneration (AMD) — historically treated with photocoagulation; wet form (H35.32) now predominantly managed with anti-VEGF; photocoagulation still used in select extrafoveal CNV cases
Laser — the primary instrument delivering the photocoagulative energy; types used include argon, diode, Nd:YAG, and pattern-scan (PASCAL) lasers
Retinal Pigment Epithelium (RPE) — the primary tissue absorbing the photocoagulative laser energy via melanin, converting light to heat at the target site
Hemoglobin — the secondary chromophore (alongside melanin) that selectively absorbs the green-wavelength laser energy to seal leaking retinal blood vessels
CODING CORNER
🏥 ICD-10-CM CODES
Diabetic Retinopathy | Most Common Photocoagulation Indications
Treatment of extensive or progressive retinopathy (e.g., diabetic retinopathy); photocoagulation (panretinal/scatter)
67229
Treatment of extensive or progressive retinopathy, 1 or more sessions, preterm infant (less than 37 weeks gestation); performed from birth up to 1 year of age (e.g., ROP); photocoagulation or cryotherapy
Fluorescein angiography (includes multiframe imaging) with interpretation and report, unilateral or bilateral (companion diagnostic to identify leaking vessels prior to photocoagulation)
Scanning computerized ophthalmic diagnostic imaging, posterior segment (OCT); retina (to confirm macular edema or CNV prior to and after treatment)
⚠️ Coding Note: For all photocoagulation CPT codes, laterality is not built into the CPT code itself — it is captured through the ICD-10-CM diagnosis code linked to the procedure; always ensure the ICD-10-CM code carries the correct eye laterality (right, left, bilateral, or unspecified) to support medical necessity and avoid claim denials. When the underlying condition drives code selection, the diagnosis is sequenced first (e.g., E11.3591 as principal/first-listed) with the procedure mapped to it — do NOT report the procedure code without a linked, billable ICD-10-CM code. A common undercoding alert on inpatient profee claims: when documentation states “macular edema” or “leaking vessels” in a diabetic patient without specifying the retinopathy stage, query the physician for stage specificity (mild, moderate, severe nonproliferative vs. proliferative) — this directly impacts the ICD-10-CM code and risk-adjustment capture. For same-day E/M services with minor photocoagulation procedures (10-day global), append modifier -25 to the E/M code if it represents a significant, separately identifiable service beyond the pre-procedure evaluation; for major procedures (90-day global), append modifier -57 to the E/M if it resulted in the decision for surgery. CPT codes 67105, 67145, 67210, 67220, 67228, and 67229 each include treatment at one or more sessions — do NOT re-bill per session if the patient returns within the global period for the same treatment.
Crystal's Coder Hub